Logo image of NUVA.DE

NORATIS AG (NUVA.DE) Stock Fundamental Analysis

FRA:NUVA - Deutsche Boerse Ag - DE000A2E4MK4 - Common Stock - Currency: EUR

1.19  +0.07 (+6.25%)

Fundamental Rating

3

Taking everything into account, NUVA scores 3 out of 10 in our fundamental rating. NUVA was compared to 74 industry peers in the Real Estate Management & Development industry. NUVA has a bad profitability rating. Also its financial health evaluation is rather negative. NUVA is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

NUVA had negative earnings in the past year.
In the past year NUVA had a positive cash flow from operations.
NUVA had positive earnings in 4 of the past 5 years.
NUVA had negative operating cash flow in 4 of the past 5 years.
NUVA.DE Yearly Net Income VS EBIT VS OCF VS FCFNUVA.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50M -50M

1.2 Ratios

NUVA has a worse Return On Assets (-6.08%) than 70.27% of its industry peers.
Looking at the Return On Equity, with a value of -42.03%, NUVA is doing worse than 77.03% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 1.00%, NUVA is in line with its industry, outperforming 55.41% of the companies in the same industry.
NUVA had an Average Return On Invested Capital over the past 3 years of 2.51%. This is in line with the industry average of 3.47%.
Industry RankSector Rank
ROA -6.08%
ROE -42.03%
ROIC 1%
ROA(3y)0.49%
ROA(5y)1.08%
ROE(3y)2.81%
ROE(5y)5.59%
ROIC(3y)2.51%
ROIC(5y)2.76%
NUVA.DE Yearly ROA, ROE, ROICNUVA.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 40 60

1.3 Margins

NUVA has a Operating Margin of 12.12%. This is comparable to the rest of the industry: NUVA outperforms 58.11% of its industry peers.
In the last couple of years the Operating Margin of NUVA has declined.
NUVA has a Gross Margin (33.21%) which is comparable to the rest of the industry.
NUVA's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 12.12%
PM (TTM) N/A
GM 33.21%
OM growth 3Y-12.49%
OM growth 5Y-25.35%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-15.23%
GM growth 5Y-19.43%
NUVA.DE Yearly Profit, Operating, Gross MarginsNUVA.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 40 60 80

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so NUVA is destroying value.
The number of shares outstanding for NUVA has been increased compared to 1 year ago.
Compared to 5 years ago, NUVA has more shares outstanding
Compared to 1 year ago, NUVA has about the same debt to assets ratio.
NUVA.DE Yearly Shares OutstandingNUVA.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M
NUVA.DE Yearly Total Debt VS Total AssetsNUVA.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M

2.2 Solvency

NUVA has an Altman-Z score of 1.35. This is a bad value and indicates that NUVA is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.35, NUVA is in the better half of the industry, outperforming 72.97% of the companies in the same industry.
The Debt to FCF ratio of NUVA is 25.77, which is on the high side as it means it would take NUVA, 25.77 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 25.77, NUVA is in line with its industry, outperforming 55.41% of the companies in the same industry.
A Debt/Equity ratio of 5.06 is on the high side and indicates that NUVA has dependencies on debt financing.
Looking at the Debt to Equity ratio, with a value of 5.06, NUVA is doing worse than 85.14% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 5.06
Debt/FCF 25.77
Altman-Z 1.35
ROIC/WACC0.3
WACC3.38%
NUVA.DE Yearly LT Debt VS Equity VS FCFNUVA.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100M 200M 300M

2.3 Liquidity

A Current Ratio of 7.75 indicates that NUVA has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 7.75, NUVA belongs to the top of the industry, outperforming 93.24% of the companies in the same industry.
NUVA has a Quick Ratio of 7.75. This is a bad value and indicates that NUVA is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.34, NUVA is not doing good in the industry: 70.27% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 7.75
Quick Ratio 0.34
NUVA.DE Yearly Current Assets VS Current LiabilitesNUVA.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M

4

3. Growth

3.1 Past

NUVA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -628.53%.
NUVA shows a decrease in Revenue. In the last year, the revenue decreased by -6.90%.
Measured over the past years, NUVA shows a small growth in Revenue. The Revenue has been growing by 1.41% on average per year.
EPS 1Y (TTM)-628.53%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-321.33%
Revenue 1Y (TTM)-6.9%
Revenue growth 3Y27.99%
Revenue growth 5Y1.41%
Sales Q2Q%-38.01%

3.2 Future

The Earnings Per Share is expected to grow by 16.58% on average over the next years. This is quite good.
NUVA is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 13.83% yearly.
EPS Next Y-154.43%
EPS Next 2Y26.68%
EPS Next 3Y24.72%
EPS Next 5Y16.58%
Revenue Next Year-2.16%
Revenue Next 2Y37.08%
Revenue Next 3Y30.59%
Revenue Next 5Y13.83%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
NUVA.DE Yearly Revenue VS EstimatesNUVA.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 50M 100M
NUVA.DE Yearly EPS VS EstimatesNUVA.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 2 -2 -4

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for NUVA. In the last year negative earnings were reported.
Also next year NUVA is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NUVA.DE Price Earnings VS Forward Price EarningsNUVA.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of NUVA is on the same level as its industry peers.
Based on the Price/Free Cash Flow ratio, NUVA is valued cheaper than 98.65% of the companies in the same industry.
Industry RankSector Rank
P/FCF 1.09
EV/EBITDA 61.17
NUVA.DE Per share dataNUVA.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 -4

4.3 Compensation for Growth

A more expensive valuation may be justified as NUVA's earnings are expected to grow with 24.72% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y26.68%
EPS Next 3Y24.72%

0

5. Dividend

5.1 Amount

NUVA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

NORATIS AG

FRA:NUVA (7/11/2025, 7:00:00 PM)

1.19

+0.07 (+6.25%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)05-25 2025-05-25/amc
Earnings (Next)09-29 2025-09-29
Inst Owners0.55%
Inst Owner ChangeN/A
Ins Owners2.11%
Ins Owner ChangeN/A
Market Cap16.15M
Analysts40
Price Target1.09 (-8.4%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.34
P/FCF 1.09
P/OCF 1.09
P/B 0.25
P/tB 0.25
EV/EBITDA 61.17
EPS(TTM)-4.25
EYN/A
EPS(NY)-0.66
Fwd EYN/A
FCF(TTM)1.09
FCFY91.87%
OCF(TTM)1.09
OCFY91.96%
SpS3.5
BVpS4.82
TBVpS4.82
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -6.08%
ROE -42.03%
ROCE 1.45%
ROIC 1%
ROICexc 1.03%
ROICexgc 1.03%
OM 12.12%
PM (TTM) N/A
GM 33.21%
FCFM 31.26%
ROA(3y)0.49%
ROA(5y)1.08%
ROE(3y)2.81%
ROE(5y)5.59%
ROIC(3y)2.51%
ROIC(5y)2.76%
ROICexc(3y)2.58%
ROICexc(5y)2.87%
ROICexgc(3y)2.58%
ROICexgc(5y)2.87%
ROCE(3y)3.63%
ROCE(5y)4%
ROICexcg growth 3Y3.42%
ROICexcg growth 5Y-34.46%
ROICexc growth 3Y3.42%
ROICexc growth 5Y-34.46%
OM growth 3Y-12.49%
OM growth 5Y-25.35%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-15.23%
GM growth 5Y-19.43%
F-Score3
Asset Turnover0.11
Health
Industry RankSector Rank
Debt/Equity 5.06
Debt/FCF 25.77
Debt/EBITDA 52.51
Cap/Depr 2.76%
Cap/Sales 0.03%
Interest Coverage 0.31
Cash Conversion 235.94%
Profit Quality N/A
Current Ratio 7.75
Quick Ratio 0.34
Altman-Z 1.35
F-Score3
WACC3.38%
ROIC/WACC0.3
Cap/Depr(3y)21.85%
Cap/Depr(5y)22.27%
Cap/Sales(3y)0.13%
Cap/Sales(5y)0.16%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-628.53%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-321.33%
EPS Next Y-154.43%
EPS Next 2Y26.68%
EPS Next 3Y24.72%
EPS Next 5Y16.58%
Revenue 1Y (TTM)-6.9%
Revenue growth 3Y27.99%
Revenue growth 5Y1.41%
Sales Q2Q%-38.01%
Revenue Next Year-2.16%
Revenue Next 2Y37.08%
Revenue Next 3Y30.59%
Revenue Next 5Y13.83%
EBIT growth 1Y-39.66%
EBIT growth 3Y12.01%
EBIT growth 5Y-24.3%
EBIT Next Year-79.85%
EBIT Next 3Y25.36%
EBIT Next 5Y23.98%
FCF growth 1Y134.63%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y134.74%
OCF growth 3YN/A
OCF growth 5YN/A